| __timestamp | Amneal Pharmaceuticals, Inc. | Eli Lilly and Company |
|---|---|---|
| Wednesday, January 1, 2014 | 335989000 | 4932500000 |
| Thursday, January 1, 2015 | 367054000 | 5037200000 |
| Friday, January 1, 2016 | 420770000 | 5654900000 |
| Sunday, January 1, 2017 | 507476000 | 6070200000 |
| Monday, January 1, 2018 | 946588000 | 4681700000 |
| Tuesday, January 1, 2019 | 1273376000 | 4721200000 |
| Wednesday, January 1, 2020 | 1364130000 | 5483300000 |
| Friday, January 1, 2021 | 1324696000 | 7312800000 |
| Saturday, January 1, 2022 | 1427596000 | 6629800000 |
| Sunday, January 1, 2023 | 1573042000 | 7082200000 |
| Monday, January 1, 2024 | 8418299999 |
Unleashing insights
In the ever-evolving pharmaceutical industry, understanding cost structures is crucial for investors and stakeholders. This chart provides a fascinating comparison of the cost of revenue between Eli Lilly and Company and Amneal Pharmaceuticals, Inc. over the past decade. From 2014 to 2023, Eli Lilly consistently outpaced Amneal, with its cost of revenue peaking at approximately $7.3 billion in 2021, a 48% increase from 2014. In contrast, Amneal's cost of revenue grew steadily, reaching around $1.57 billion in 2023, marking a 368% increase since 2014. This stark contrast highlights Eli Lilly's larger scale and market presence, while Amneal's rapid growth underscores its expanding footprint in the industry. Such insights are invaluable for understanding the financial dynamics and strategic positioning of these pharmaceutical powerhouses.
Eli Lilly and Company vs Regeneron Pharmaceuticals, Inc.: Efficiency in Cost of Revenue Explored
Comparing Cost of Revenue Efficiency: Eli Lilly and Company vs Johnson & Johnson
Cost of Revenue Comparison: Eli Lilly and Company vs Biogen Inc.
Comparing Cost of Revenue Efficiency: Eli Lilly and Company vs Viatris Inc.
Cost Insights: Breaking Down Eli Lilly and Company and Telix Pharmaceuticals Limited's Expenses
Comparing Cost of Revenue Efficiency: Eli Lilly and Company vs Ionis Pharmaceuticals, Inc.
Cost Insights: Breaking Down Eli Lilly and Company and Geron Corporation's Expenses
Novo Nordisk A/S vs Amneal Pharmaceuticals, Inc.: Efficiency in Cost of Revenue Explored
Cost of Revenue Comparison: Novartis AG vs Amneal Pharmaceuticals, Inc.
Cost of Revenue Comparison: Sarepta Therapeutics, Inc. vs Amneal Pharmaceuticals, Inc.
Cost of Revenue: Key Insights for Amneal Pharmaceuticals, Inc. and ACADIA Pharmaceuticals Inc.
Cost Insights: Breaking Down Amneal Pharmaceuticals, Inc. and Galapagos NV's Expenses